We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$752M
AUM Growth
+$110M
Cap. Flow
+$81.1M
Cap. Flow %
10.79%
Top 10 Hldgs %
40.28%
Holding
184
New
49
Increased
34
Reduced
33
Closed
54

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$17.2M
2
ORCL icon
Oracle
ORCL
+$13.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$12.5M
4
NGD
New Gold Inc
NGD
+$10.2M
5
INCY icon
Incyte
INCY
+$9.49M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17.2M
2
SSNI
Silver Spring Networks, Inc.
SSNI
+$12.8M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BRG
Bluerock Residential Growth REIT, Inc.
BRG
+$8.05M
5
MKTX icon
MarketAxess Holdings
MKTX
+$7.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.31%
2 Technology 13.37%
3 Materials 7.6%
4 Utilities 6.6%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBT icon
1
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$56.9M 7.57%
+1,600,000
New +$56.4M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$50.2M 6.68%
+200,000
New +$49.3M
AY
3
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$39.1M 5.2%
1,984,000
+361,600
+22% +$7.51M
HASI icon
4
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$27.2M 3.61%
1,115,363
-64,637
-5% -$1.51M
ALXN
5
DELISTED
Alexion Pharmaceuticals
ALXN
$24.1M 3.2%
171,500
-5,000
-3% -$679K
XBI icon
6
State Street SPDR S&P Biotech ETF
XBI
$10B
$23.2M 3.09%
268,000
-8,000
-3% -$641K
VRTX icon
7
CALL
Vertex Pharmaceuticals
VRTX
$123B
$22.8M 3.03%
+150,000
New +$22.6M
STKL
8
DELISTED
SunOpta
STKL
$20.6M 2.74%
2,365,000
+36,600
+2% +$332K
RITM icon
9
Rithm Capital
RITM
$5.58B
$19.4M 2.58%
1,160,000
+160,000
+16% +$2.62M
CNC icon
10
Centene
CNC
$30.5B
$19.4M 2.57%
+400,000
New +$17.2M
PE
11
DELISTED
PARSLEY ENERGY INC
PE
$15.8M 2.1%
600,000
-25,000
-4% -$659K
PGNX
12
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$14.1M 1.87%
1,910,000
+1,400,000
+275% +$8.89M
ZBH icon
13
Zimmer Biomet
ZBH
$18.8B
$12.9M 1.71%
113,300
+108,665
+2,344% +$12.5M
ORCL icon
14
Oracle
ORCL
$339B
$12.8M 1.7%
+265,000
New +$13.2M
FTAI icon
15
FTAI Aviation
FTAI
$20.2B
$12.8M 1.7%
831,410
-58,550
-7% -$857K
MSFT icon
16
Microsoft
MSFT
$2.9T
$11.7M 1.56%
157,500
+35,500
+29% +$2.59M
SHPG
17
CALL
DELISTED
Shire pic
SHPG
$11.5M 1.53%
75,000
-75,000
-50% -$11.8M
GPRE icon
18
Green Plains
GPRE
$1.15B
$11.4M 1.51%
565,000
+320,000
+131% +$6.11M
JAZZ icon
19
Jazz Pharmaceuticals
JAZZ
$16.1B
$11.3M 1.5%
77,000
+17,000
+28% +$2.57M
NGD
20
DELISTED
New Gold Inc
NGD
$11M 1.46%
+2,965,000
New +$10.2M
URI icon
21
United Rentals
URI
$65.7B
$10.4M 1.38%
75,000
-5,000
-6% -$597K
POT
22
DELISTED
Potash Corp Of Saskatchewan
POT
$10.2M 1.36%
+530,000
New +$9.45M
NSM
23
DELISTED
Nationstar Mortgage Holdings
NSM
$10.1M 1.34%
542,500
-7,500
-1% -$131K
CIO
24
DELISTED
City Office REIT
CIO
$10.1M 1.34%
730,000
-10,000
-1% -$127K
CWEN.A
25
DELISTED
Clearway Energy Class A
CWEN.A
$9.81M 1.3%
517,000
+20,000
+4% +$362K
1
2 3 4 5

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Ardsley Advisory Partners held 184 positions worth $752M, up 17% from $642M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ardsley Advisory Partners deployed $81.1M of net new capital in Q3 2017, opening 49 new positions and adding to 34 existing holdings. Its largest new stake was Centene: 400,000 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Celgene Corp, an estimated $17.2M trimmed.

  • Ardsley Advisory Partners's largest Q3 2017 buy was Centene: 400,000 shares worth $19.4M.
  • Ardsley Advisory Partners added most to Zimmer Biomet in Q3 2017, an estimated $12.5M increase.
  • Ardsley Advisory Partners's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $17.2M.
  • Ardsley Advisory Partners fully exited Bluerock Residential Growth REIT, Inc. in Q3 2017, selling an estimated $8.05M.
  • Ardsley Advisory Partners's ten largest holdings make up 40% of its $752M portfolio in Q3 2017.
  • Ardsley Advisory Partners opened 49 new positions and closed 54 in Q3 2017.
  • Ardsley Advisory Partners's portfolio value rose 17% quarter-over-quarter to $752M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.